LIVE EVENT Q&A: Dr. Andrew Huberman at the ICC Sydney Theatre

Recorded live at the ICC Theatre in Sydney, this episode is the audience question-and-answer portion of Huberman's 'Brain Body Contract' event. Huberman answers practical questions on napping, entering a rest-and-digest state, and how learning and rest interact in the brain. A long stretch covers psychedelics and hallucinogens, where he discusses clinical-trial evidence for psilocybin, MDMA, ketamine, ibogaine, and DMT while urging caution. He also covers the placebo effect's dose-dependence, the gut-brain axis and microbiome support, sleep chronotypes and regularity, and behavioral plus visual-focus tools for ADHD.

• Huberman champions NSDR (non-sleep deep rest), citing University of Copenhagen studies showing it replenishes brain dopamine.
  00:04:45
• Describes a dose-dependent placebo effect study where being TOLD you got a higher nicotine dose changed cognition and measured brain activity even at zero dose.
  00:07:52
• Admits he took LSD and psilocybin 'all too young,' calls them bad experiences, and says he does not recommend them.
  00:20:24
• Reveals he participated in two clinical trials of high-dose psilocybin (over two grams, taken twice with therapist support).
  00:21:59
• Explains the famous 'MDMA puts holes in your brain' paper was retracted because researchers accidentally dosed subjects with methamphetamine.
  00:27:12
• States that ketamine and the demonized drug PCP are the same compound.
  00:30:19
• Discloses the podcast funds human-only studies of compounds like DMT (Robin Carhart-Harris's lab) and an eating-disorders lab at Columbia.
  00:32:52

• Keep naps shorter than 90 minutes so they don't disrupt nighttime sleep; skip them entirely if they do.
  00:04:13
• In nicotine cognition studies, what subjects believed they were dosed with changed both performance and recorded brain activity.
  00:09:54
• Optimal learning difficulty is roughly 85% correct trials and 15% errors.
  00:17:12
• The agitation and frustration of failing is the neurochemical stimulus for neuroplasticity; the actual rewiring happens during sleep and rest.
  00:18:13
• Most psychedelic trials use psilocybin over LSD partly because an LSD trip is far longer than a clinician's workday; ibogaine runs about 22 hours.
  00:23:00
• Kentucky directed $40 million of its opioid settlement toward ibogaine trials.
  00:24:05
• MDMA-assisted therapy shows up to 60-67% remission of PTSD with proper dosing and support.
  00:27:43
• The best low-cost way to support the gut-brain axis is one to four daily servings of low-sugar fermented foods like kimchi, sauerkraut, or kefir.
  00:38:00
• Sleep regularity matters: aim to keep bedtime within plus or minus one hour, about five nights a week.
  00:41:39
• Chinese focus-training studies improve attention by having people fixate on a visual target for one to three minutes before working.
  00:45:46